BioCentury
ARTICLE | Company News

Hollis-Eden, Pharmadigm deal

September 3, 2002 7:00 AM UTC

HEPH gained exclusive global rights to certain undisclosed patents from Pharmadigm and the University of Utah. The patents relate to HEPH's Immune Regulating Hormones (IRH) for treating infectious dis...